Role of (−)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers

被引：0
|
作者：
Osamu Abe
Tomoyuki Ono
Hideyuki Sato
Fabian Müller
Hiroshi Ogata
Itaru Miura
Yayoi Shikama
Hirooki Yabe
Satomi Onoue
Martin F. Fromm
Junko Kimura
Shingen Misaka
机构：
[1] Fukushima Medical University,Department of Pharmacology, School of Medicine
[2] Fukushima Medical University,Department of Neuropsychiatry, School of Medicine
[3] University of Shizuoka,Department of Pharmacokinetics and Pharmacodynamics, School of Pharmaceutical Sciences
[4] Friedrich-Alexander-Universität Erlangen-Nürnberg,Institute of Experimental and Clinical Pharmacology and Toxicology
[5] Fukushima Medical University,Centre for Medical Education and Career Development
来源：
European Journal of Clinical Pharmacology | 2018年 / 74卷
关键词：
Drug interaction; (−)-epigallocatechin gallate; Green tea; Nadolol; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：775 / 783
页数：8
相关论文
共 50 条
  • [1] Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers
    Abe, Osamu
    Ono, Tomoyuki
    Sato, Hideyuki
    Mueller, Fabian
    Ogata, Hiroshi
    Miura, Itaru
    Shikama, Yayoi
    Yabe, Hirooki
    Onoue, Satomi
    Fromm, Martin F.
    Kimura, Junko
    Misaka, Shingen
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (06) : 775 - 783
  • [2] Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers
    Shingen Misaka
    Osamu Abe
    Hideyuki Sato
    Tomoyuki Ono
    Yayoi Shikama
    Satomi Onoue
    Hirooki Yabe
    Junko Kimura
    European Journal of Clinical Pharmacology, 2018, 74 : 601 - 609
  • [3] Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers
    Misaka, Shingen
    Abe, Osamu
    Sato, Hideyuki
    Ono, Tomoyuki
    Shikama, Yayoi
    Onoue, Satomi
    Yabe, Hirooki
    Kimura, Junko
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (05) : 601 - 609
  • [4] Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers
    Kim, Tae-Eun
    Ha, Na
    Kim, Yunjeong
    Kim, Hyunsook
    Lee, Jae Wook
    Jeon, Ji-Young
    Kim, Min-Gul
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1409 - 1416
  • [5] Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteers
    Misaka, Shingen
    Abe, Osamu
    Ono, Tomoyuki
    Ono, Yuko
    Ogata, Hiroshi
    Miura, Itaru
    Shikama, Yayoi
    Fromm, Martin F.
    Yabe, Hirooki
    Shimomura, Kenju
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (11) : 2314 - 2318
  • [6] Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats
    Misaka, S.
    Miyazaki, N.
    Fukushima, T.
    Yamada, S.
    Kimura, J.
    PHYTOMEDICINE, 2013, 20 (14) : 1247 - 1250
  • [7] Pharmacokinetic and Pharmacodynamic Interaction of Nadolol With Itraconazole, Rifampicin and Grapefruit Juice in Healthy Volunteers
    Misaka, Shingen
    Miyazaki, Nozomu
    Yatabe, Midori S.
    Ono, Tomoyuki
    Shikama, Yayoi
    Fukushima, Tetsuhito
    Kimura, Junko
    JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 53 (07) : 738 - 745
  • [8] BINDING INTERACTION BETWEEN (-)-EPIGALLOCATECHIN-3-GALLATE (EGCG) OF GREEN TEA AND PEPSIN
    Li, Y.
    Lu, F. Q.
    Feng, Y.
    He, Z. D.
    Wu, X. L.
    ACTA ALIMENTARIA, 2016, 45 (01) : 129 - 140
  • [9] Pharmacokinetic and Pharmacodynamic Interaction between Metformin and (-)-Epigallocatechin-3-gallate
    Ko, Jeong-Hyeon
    Jang, Eun-Hee
    Park, Chang-Shin
    Kim, Hyoung-Kwang
    Cho, Soon Gu
    Shin, Dong Wun
    Yi, Hyeon Gyu
    Kang, Ju-Hee
    MOLECULAR & CELLULAR TOXICOLOGY, 2009, 5 (04) : 298 - 303
  • [10] Crystal Engineering of Green Tea Epigallocatechin-3-gallate (EGCg) Cocrystals and Pharmacokinetic Modulation in Rats
    Smith, Adam J.
    Kavuru, Padmini
    Arora, Kapildev K.
    Kesani, Sheshanka
    Tan, Jun
    Zaworotko, Michael J.
    Shytle, R. Douglas
    MOLECULAR PHARMACEUTICS, 2013, 10 (08) : 2948 - 2961
12345